Evaluation of Lipoprotein Profile and Residual Risk Three Years After Bariatric Surgery

Obes Surg. 2021 Sep;31(9):4033-4044. doi: 10.1007/s11695-021-05543-2. Epub 2021 Jul 10.

Abstract

Introduction: Obesity is a chronic disease associated with other comorbidities, including atherogenic dyslipidemia (AD). Bariatric surgery (BS) has shown to reduce cardiovascular risk (CVR) by achieving a significant weight reduction and improving the lipid profile. Different surgical techniques may have a different effect on the lipoprotein profile.

Purpose: To evaluate the lipid profile at 3 years after BS according to the surgical technique used and to determine which variables predict variation in the lipid profile at 3 years after BS.

Methods: Retrospective observational study of 206 patients who underwent BS between 2010 and 2019. We analyzed the variation of lipid parameters in the 3 years of follow-up according to the surgical technique, including a group analysis of patients according to whether they had dyslipidemia and whether they were treated or untreated and determined which variables predict variation in the lipid profile at 3 years after BS.

Results: There was a significant increase in high-density lipoprotein cholesterol (HDL-c) with sleeve gastrectomy (SG) and a significant decrease in total cholesterol (TC), LDL-cholesterol (LDL-c), non-HDL, and LDL/non-HDL with biliopancreatic diversion (BPD). Variables predicting lipid profile variation were surgical technique and pre-surgery lipoprotein level.

Conclusions: Malabsorptive techniques achieve a greater decrease in TC and LDL-c throughout follow-up and could also improve residual cardiovascular risk (non-HDL and LDL/non-HDL). The type of surgical technique and the presurgery lipid profile predict variation after 3 years of BS.

Keywords: Bariatric surgery; Dyslipidemia; Obesity; Residual cardiovascular risk.

Publication types

  • Observational Study

MeSH terms

  • Bariatric Surgery*
  • Cholesterol, HDL
  • Dyslipidemias* / surgery
  • Gastrectomy
  • Humans
  • Obesity, Morbid* / surgery
  • Triglycerides
  • Weight Loss

Substances

  • Cholesterol, HDL
  • Triglycerides